Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infarcted myocardium

Biochemical and Biophysical Research Communications

Volumn 402, Issue 2, 2010, Pages 272-279

  Eun, Lucy Youngmin ^a   Song, Byeong Wook ^b   Cha, Min Ji ^b   Song, Heesang ^b   Kim, Il Kwon ^b   Choi, Eunmi ^b   Chang, Woochul ^b   Lim, Soyeon ^b   Choi, Eun Ju ^b   Ham, Onju ^b   Lee, Se Yeon ^b   Byun, Ki Hyun ^a   Jang, Yangsoo ^b   Hwang, Ki Chul ^b  

^a Kwandong University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cardiac regeneration; Lentivirus; Mesenchymal stem cells; Phosphoinositide 3 kinase class II alpha; Survival

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER; CELL COUNT; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART FUNCTION; HEART INFARCTION; MALE; MESENCHYMAL STEM CELL; MICROVASCULATURE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGENERATION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CLASS II PHOSPHATIDYLINOSITOL 3-KINASES; GENETIC ENGINEERING; HEART; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION;

LENTIVIRUS; RATTUS;

EID: 78149470891     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.10.013     Document Type: Article

References (31)

1. Frangogiannis N.G. The immune system and cardiac repair. Pharmacol. Res. 2008, 58:88-111.
2. Christoforou N., Gearhart J.D. Stem cells and their potential in cell-based cardiac therapies. Prog. Cardiovasc. Dis. 2007, 49:396-413.
3. Krabbe C., Zimmer J., Meyer M. Neural transdifferentiation of mesenchymal stem cells - a critical review. APMIS 2005, 113:831-844.
4. Laflamme M.A., Murry C.E. Regenerating the heart. Nat. Biotechnol. 2005, 23:845-856.
5. Nagaya N., Kangawa K., Itoh T., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005, 112:1128-1135.
6. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 2005, 102:11474-11479.
7. Kovacic J.C., Graham R.M. Stem-cell therapy for myocardial diseases. Lancet 2004, 363:1735-1736.
8. Wollert K.C., Drexler H. Cell-based therapy for heart failure. Curr. Opin. Cardiol. 2006, 21:234-239.
9. Zhang M., Methot D., Poppa V., et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell Cardiol. 2001, 33:907-921.
10. Haider H., Ashraf M. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J. Mol. Cell. Cardiol. 2008, 45:554-566.
11. Hodgetts S.I., Beilharz M.W., Scalzo A.A., et al. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant. 2000, 9:489-502.
12. Shaw R.J., Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006, 441:424-430.
13. Engelman J.A., Luo J., Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 2006, 7:606-619.
14. Wymann M.P., Marone R. Phosphoinositide 3-kinase in disease: timing, Location, and scaffolding. Curr. Opin. Cell Biol. 2005, 17:141-149.
15. Traer C.J., Foster F.M., Abraham S.M., et al. Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?. Bull. Cancer 2006, 93:E53-E58.
16. Song H., Chang W., Lim S., et al. Tissue transglutaminase is essential for integrin-mediated survival of bone marrow-derived mesenchymal stem cells. Stem Cells 2007, 25:1431-1438.
17. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 2001, 7:430-436.
18. van Laake L.W., Passier R., Doevendans P.A., et al. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ. Res. 2008, 102:1008-1010.
19. Taylor D.A., Atkins B.Z., Hungspreugs P., et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat. Med. 1998, 4:929-933.
20. Barbash I.M., Chouraqui P., Baron J., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility cell migration, and body distribution. Circulation 2003, 108:863-868.
21. Berry M.F., Engler A.J., Woo Y.J., et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H2196-H2203.
22. Toma C., Pittenger M.F., Cahill K.S., et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002, 105:93-98.
23. Song S.W., Chang W., Song B.W., et al. Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem cells 2009, 27:1358-1365.
24. Noiseux N., Gnecchi M., Lopez-Ilasaca M., et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol. Ther. 2006, 14:840-850.
25. Wu C.J., O'Rourke D.M., Feng G.S., et al. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Oncogene 2001, 20:6018-6025.
26. Turner S.J., Domin J., Waterfield M.D., et al. The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2alpha. J. Biol. Chem. 1998, 273:25987-25995.
27. Elis W., Triantafellow E., Wolters N.M., et al. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death. Mol. Cancer Res. 2008, 6:614-623.
28. Kang S., Song J., Kang J., et al. Suppression of the alpha-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death. Biochem. Biophys. Res. Commun. 2005, 329:6-10.
29. Datta S.R., Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
30. Deng J., Han Y., Yan C., et al. Overexpressing cellular repressor of E1A-stimulated genes protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt. Apoptosis 2010, 15:463-473.
31. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999, 13:1899-1911.